JCG
HALO icon

JHL Capital Group’s Halozyme HALO Stock Holding History

JHL Capital Group’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-375,000
Closed -$5.36M – 25
2015
Q1 		$5.36M Sell
375,000
-1,100,000
-75% -$15.9M 0.49% 18
2014
Q4 		$14.2M Buy
1,475,000
+50,000
+4% +$444K 0.94% 17
2014
Q3 		$13M Buy
1,425,000
+325,000
+30% +$3.1M 0.7% 19
2014
Q2 		$10.9M Buy
+1,100,000
New +$9.33M 0.52% 20

Other funds holding HALO

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JHL Capital Group's HALO Position: Q2 2015 in Review

JHL Capital Group sold out of Halozyme (HALO) in Q2 2015, closing a stake of 375,000 shares — an estimated $5.36M sold.

JHL Capital Group first reported a position in HALO in Q2 2014 and held it in 4 quarters. The position peaked at $14.2M in Q4 2014. 158 funds tracked by Wall St. Rank hold HALO as of Q2 2015.

  • JHL Capital Group reported no remaining Halozyme position as of Q2 2015 after selling out during the quarter.
  • JHL Capital Group sold 375,000 Halozyme shares in Q2 2015, an estimated $5.36M.
  • JHL Capital Group first reported a position in Halozyme in Q2 2014 and held it in 4 quarters.
  • JHL Capital Group's Halozyme position peaked at $14.2M in Q4 2014.
  • 158 funds tracked by Wall St. Rank held Halozyme as of Q2 2015.

Based on JHL Capital Group's 13F filing for Q2 2015, filed 14 Aug 2015.